Humphrey Mulenga

3.0k total citations
33 papers, 427 citations indexed

About

Humphrey Mulenga is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Humphrey Mulenga has authored 33 papers receiving a total of 427 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Infectious Diseases, 25 papers in Epidemiology and 12 papers in Surgery. Recurrent topics in Humphrey Mulenga's work include Tuberculosis Research and Epidemiology (30 papers), Pneumonia and Respiratory Infections (11 papers) and Mycobacterium research and diagnosis (11 papers). Humphrey Mulenga is often cited by papers focused on Tuberculosis Research and Epidemiology (30 papers), Pneumonia and Respiratory Infections (11 papers) and Mycobacterium research and diagnosis (11 papers). Humphrey Mulenga collaborates with scholars based in South Africa, United States and United Kingdom. Humphrey Mulenga's co-authors include Mark Hatherill, Michèle Tameris, Willem A. Hanekom, Thomas J. Scriba, Hassan Mahomed, Gregory Hussey, Hennie Geldenhuys, Suzanne Verver, Angelique Kany Kany Luabeya and Simon C. Mendelsohn and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Humphrey Mulenga

33 papers receiving 425 citations

Peers

Countries citing papers authored by Humphrey Mulenga

Since Specialization

Citations

This map shows the geographic impact of Humphrey Mulenga's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Humphrey Mulenga with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Humphrey Mulenga more than expected).

Fields of papers citing papers by Humphrey Mulenga

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Humphrey Mulenga. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Humphrey Mulenga. The network helps show where Humphrey Mulenga may publish in the future.

Co-authorship network of co-authors of Humphrey Mulenga

This figure shows the co-authorship network connecting the top 25 collaborators of Humphrey Mulenga. A scholar is included among the top collaborators of Humphrey Mulenga based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Humphrey Mulenga. Humphrey Mulenga is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Screening for asymptomatic tuberculosis among adults with household exposure to pulmonary tuberculosis: a prospective observational cohort study 2025 ·The Lancet Global Health ·Simon C. Mendelsohn, Humphrey Mulenga, Michèle Tameris, (unknown), Stephanus T. Malherbe, (unknown), Fernanda Maruri, (unknown), Ravindre Panchia, Khuthadzo Hlongwane, Kim Stanley, Yuri F. van der Heijden, Katie Hadley, (unknown), Novel N. Chegou, Gerhard Walzl, Thomas J. Scriba, Timothy R. Sterling, Mark Hatherill	1
2	Prospective multicentre head-to-head validation of host blood transcriptomic biomarkers for pulmonary tuberculosis by real-time PCR 2022 ·SHILAP Revista de lepidopterología ·Simon C. Mendelsohn, Stanley Kimbung Mbandi, Andrew Fioré-Gartland, Adam Penn‐Nicholson, Munyaradzi Musvosvi, Humphrey Mulenga, Michelle Fisher, Katie Hadley, Mzwandile Erasmus, (unknown), Michèle Tameris, Gerhard Walzl, Kogieleum Naidoo, Gavin Churchyard, Mark Hatherill, Thomas J. Scriba	20
3	The effect of host factors on discriminatory performance of a transcriptomic signature of tuberculosis risk 2022 ·EBioMedicine ·Humphrey Mulenga, Andrew Fioré-Gartland, Simon C. Mendelsohn, Adam Penn‐Nicholson, Stanley Kimbung Mbandi, Bhavesh Borate, Munyaradzi Musvosvi, Michèle Tameris, Gerhard Walzl, Kogieleum Naidoo, Gavin Churchyard, Thomas J. Scriba, Mark Hatherill	4
4	Clinical predictors of pulmonary tuberculosis among South African adults with HIV 2022 ·EClinicalMedicine ·Simon C. Mendelsohn, Andrew Fioré-Gartland, (unknown), Humphrey Mulenga, Stanley Kimbung Mbandi, Michèle Tameris, Gerhard Walzl, Kogieleum Naidoo, Gavin Churchyard, Thomas J. Scriba, Mark Hatherill	11
5	Inflammation and immune activation are associated with risk of Mycobacterium tuberculosis infection in BCG-vaccinated infants 2022 ·Nature Communications ·Iman Satti, (unknown), Shuailin Li, Stephanie A. Harris, Rachel Tanner, Deniz Cizmeci, (unknown), Nicola Williams, Humphrey Mulenga, Helen A. Fletcher, Thomas J. Scriba, Michèle Tameris, Mark Hatherill, Helen McShane	14
6	Molecular Detection of Airborne Mycobacterium tuberculosis in South African High Schools 2021 ·American Journal of Respiratory and Critical Care Medicine ·(unknown), Keren Middelkoop, Anastasia Koch, (unknown), Humphrey Mulenga, Angelique Kany Kany Luabeya, Justin Shenje, Simon C. Mendelsohn, Michèle Tameris, Thomas J. Scriba, Digby F. Warner, Robin Wood, Jason R. Andrews, Mark Hatherill	12
7	Performance of diagnostic and predictive host blood transcriptomic signatures for Tuberculosis disease: A systematic review and meta-analysis 2020 ·PLoS ONE ·Humphrey Mulenga, (unknown), (unknown), Stanley Kimbung Mbandi, Simon C. Mendelsohn, Benjamin M. Kagina, Adam Penn‐Nicholson, Thomas J. Scriba, Mark Hatherill	39
8	Regional changes in tuberculosis disease burden among adolescents in South Africa (2005–2015) 2020 ·PLoS ONE ·(unknown), Humphrey Mulenga, Angelique Kany Kany Luabeya, Justin Shenje, Simon C. Mendelsohn, Elisa Nemes, Michèle Tameris, Robin Wood, Thomas J. Scriba, Mark Hatherill	6
9	Performance of host blood transcriptomic signatures for diagnosing and predicting progression to tuberculosis disease in HIV-negative adults and adolescents: a systematic review protocol 2019 ·BMJ Open ·Humphrey Mulenga, (unknown), Stanley Kimbung Mbandi, Simon C. Mendelsohn, Benjamin M. Kagina, Adam Penn‐Nicholson, Thomas J. Scriba, Mark Hatherill	5
10	Toll-like receptor chaperone HSP90B1 and the immune response to Mycobacteria 2018 ·PLoS ONE ·(unknown), Elizabeth Ann Misch, Munyaradzi Musvosvi, Muki Shey, Javeed A. Shah, Chetan Seshadri, (unknown), Kathryn Bowman, Humphrey Mulenga, Ashley Veldsman, Willem A. Hanekom, Mark Hatherill, Thomas J. Scriba, Thomas R. Hawn	19
11	Safety and Immunogenicity of Newborn MVA85A Vaccination and Selective, Delayed Bacille Calmette-Guerin (BCG) for Infants of HIV Infected Mothers: A Phase 2 Randomized Controlled Trial. 2017 ·Clinical Infectious Diseases ·Elisa Nemes, A C Hesseling, Michèle Tameris, Katya Mauff, Katrina Downing, Humphrey Mulenga, (unknown), (unknown), (unknown), (unknown), Willem A. Hanekom, Gerhard Walzl, Thomas J. Scriba, Helen McShane, Mark Hatherill	1
12	Prevalence of latent TB infection and TB disease among adolescents in high TB burden countries in Africa: a systematic review protocol 2017 ·BMJ Open ·(unknown), Bey‐Marrié Schmidt, Leila Abdullahi, Humphrey Mulenga, Michèle Tameris, Angelique Kany Kany Luabeya, Justin Shenje, Thomas J. Scriba, Hennie Geldenhuys, Robin Wood, Mark Hatherill	3
13	Impact of Xpert MTB/RIF rollout on management of tuberculosis in a South African community 2017 ·South African Medical Journal ·(unknown), Hennie Geldenhuys, Michèle Tameris, Angelique Kany Kany Luabeya, Humphrey Mulenga, (unknown), Thomas J. Scriba, Mark Hatherill	15
14	Evaluation of Xpert® MTB/RIF Assay in Induced Sputum and Gastric Lavage Samples from Young Children with Suspected Tuberculosis from the MVA85A TB Vaccine Trial 2015 ·PLoS ONE ·(unknown), Michèle Tameris, Hennie Geldenhuys, Bey‐Marrié Schmidt, Angelique Kany Kany Luabeya, Humphrey Mulenga, Thomas J. Scriba, Willem A. Hanekom, Hassan Mahomed, Helen McShane, Mark Hatherill	19
15	The Role of Clinical Symptoms in the Diagnosis of Intrathoracic Tuberculosis in Young Children 2015 ·The Pediatric Infectious Disease Journal ·Humphrey Mulenga, Michèle Tameris, Angelique Kany Kany Luabeya, Hennie Geldenhuys, Thomas J. Scriba, Gregory Hussey, Hassan Mahomed, Bernard Landry, Willem A. Hanekom, Helen McShane, Mark Hatherill	18
16	Risk of Disease After Isoniazid Preventive Therapy for Mycobacterium tuberculosis Exposure in Young HIV-uninfected Children 2015 ·The Pediatric Infectious Disease Journal ·Angelique Kany Kany Luabeya, Michèle Tameris, Hennie Geldenhuys, Humphrey Mulenga, (unknown), E. Jane Hughes, (unknown), Thomas J. Scriba, Gregory Hussey, Hassan Mahomed, Helen McShane, Bernard Landry, Willem A. Hanekom, Mark Hatherill	7
17	Screening for TB in high school adolescents in a high burden setting in South Africa 2013 ·Tuberculosis ·Hassan Mahomed, Rodney Ehrlich, Tony Hawkridge, Mark Hatherill, Lawrence Geiter, Fazlin Kafaar, Deborah Abrahams, Humphrey Mulenga, Michèle Tameris, Hennie Geldenhuys, Willem A. Hanekom, Suzanne Verver, Gregory Hussey	18
18	TB Incidence in an Adolescent Cohort in South Africa 2013 ·PLoS ONE ·Hassan Mahomed, Rodney Ehrlich, Tony Hawkridge, Mark Hatherill, Lawrence Geiter, Fazlin Kafaar, Deborah Abrahams, Humphrey Mulenga, Michèle Tameris, Hennie Geldenhuys, Willem A. Hanekom, Suzanne Verver, Gregory Hussey	48
19	Predictive Value of Recent QuantiFERON Conversion for Tuberculosis Disease in Adolescents 2012 ·American Journal of Respiratory and Critical Care Medicine ·Shingai Machingaidze, Suzanne Verver, Humphrey Mulenga, (unknown), Mark Hatherill, Willem A. Hanekom, Gregory Hussey, Hassan Mahomed	55
20	Diagnostic Features Associated With Culture of Mycobacterium tuberculosis Among Young Children in a Vaccine Trial Setting 2011 ·The Pediatric Infectious Disease Journal ·Angelique Kany Kany Luabeya, Humphrey Mulenga, Sizulu Moyo, Michèle Tameris, Welile Sikhondze, Hennie Geldenhuys, (unknown), Willem A. Hanekom, Gregory Hussey, Mark Hatherill	7

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact